Advertisement
Development assistance for adolescent health makes up a small proportion of total development assistance for health

Little Global Development Assistance for Adolescent Health

0
Overall, 1.6 percent of total development assistance for health went to projects with adolescent target
Audiovisual tobacco content remains common in prime-time U.K. television programs and is virtually unchanged from 2010

Tobacco Content Still Common on U.K. Prime-Time Television

0
Tobacco content occurred in 33 percent of all programs; 8 percent of all adverts, trailer breaks
Life expectancy has declined in recent years in some high-income countries

Declines in Life Expectancy in Many High-Income Countries

0
And increase in midlife death rates across racial and ethnic groups in the United States
First-year residents experience worsening sleep duration and quality as well as daytime sleepiness

Residents’ Sleep Deteriorates During Training

0
Worsening seen for sleep duration, quality of sleep, and daytime sleepiness
From 2014 to 2017 there was an increase in tianeptine exposure calls reported by poison control centers to the National Poison Data System

CDC: Increase in Tianeptine Exposures From 2014 to 2017

0
Most commonly reported health effects were neurologic, cardiovascular, and gastrointestinal
Administering the Visual Association Test improves the predictive value of the Mini-Mental State Examination score for dementia

VAT Score Improves Predictive Value of MMSE for Dementia

0
Imperfect VAT score plus decline in MMSE score over two years helps identify those at higher risk
Systematic screening for anxiety

Psych Screening Beneficial in Pediatric Abdominal Pain

0
Children with abdominal pain commonly had clinically significant anxiety, moderate disability, pain
A U.S. National Institutes of Health oversight panel will no longer review all applications for gene therapy experiments. Instead

Comments Open on End of NIH Review for Gene Therapy Studies

0
NIH oversight panel no longer plans to review all applications for gene therapy experiments
A brain stimulation device to treat obsessive-compulsive disorder has received approval for marketing by the U.S. Food and Drug Administration.

FDA Permits Marketing of Brain Stimulation Device for OCD

0
FDA previously approved transcranial magnetic stimulation for major depression, certain migraines
Certain steps should be taken when discharging a patient for failure or inability to meet financial obligations

Steps Provided for Discharging Patient From Practice

0
Letter should be sent informing patient of their discharge, providing at least 30 days' notice